Revelation Biosciences REVB
NASDAQ REVB
$0.80 -0.01 (-0.73%)
As of: Oct 2, 2026 · 10:13 AM EDT

Revelation Biosciences (REVB) Depreciation & Amortization (CF) (2021 - 2026)

Updated

Revelation Biosciences' Depreciation & Amortization (CF) came in at $8,313 for Q2 2026, up 15.1% from $7,220 a year earlier and up 15.4% from the prior quarter.

Analysis

Revelation Biosciences (REVB) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Revelation Biosciences reported Depreciation & Amortization (CF) of $28,133, down 2.6% year-over-year; for FY2025, it was $27,058, down 3.1% from FY2024.

  • Depreciation & Amortization (CF) carries a four-year compound annual growth rate of 12.7% (FY2021 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $27,923 in FY2024 (+11.5%), $25,049 in FY2023 (unchanged), $25,048 in FY2022 (+49.3%) and $16,782 in FY2021.
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2021.
  • Year-over-year, Depreciation & Amortization (CF) increased in four of the last eight quarters, with growth averaging 4.4%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2022 (growth of 875.4%), and the weakest in Q4 2025 (a decline of 19.0%).
  • Business Quant data shows REVB's Depreciation & Amortization (CF) at $7,203 (Q1 2026), $5,852 (Q4 2025) and $6,765 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Revelation Biosciences 3.20 Mn -45.82 Mn - 8,313.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8,313.00
Mar 31, 2026 7,203.00
Dec 31, 2025 5,852.00
Sep 30, 2025 6,765.00
Jun 30, 2025 7,220.00
Mar 31, 2025 7,221.00
Dec 31, 2024 7,221.00
Sep 30, 2024 7,220.00
Jun 30, 2024 7,220.00
Mar 31, 2024 6,262.00
Dec 31, 2023 6,262.00
Sep 30, 2023 6,262.00
Jun 30, 2023 6,262.00
Mar 31, 2023 6,263.00
Dec 31, 2022 6,262.00
Sep 30, 2022 6,262.00
Jun 30, 2022 6,262.00
Mar 31, 2022 6,262.00
Dec 31, 2021 6,262.00
Sep 30, 2021 6,071.00
API Access

Revelation Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=REVB&period=max&api_key=YOUR_API_KEY